Cargando…
3. Statin induced immune mediated necrotising myopathy: a case report
INTRODUCTION: Statins are a commonly used group of drugs which lowers low density lipoprotein (LDL) levels by competitively inhibiting 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase. Though they are effective and safe, about 0.1% patients on statins can develop severe myonecrosis or immun...
Autores principales: | Banerjee, Siwalik, Dubey, Shirish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761404/ http://dx.doi.org/10.1093/rap/rkz026.002 |
Ejemplares similares
-
Atorvastatin: Statin induced autoimmune necrotising myopathy: case report
Publicado: (2022) -
Tozinameran: Immune-mediated necrotising myopathy: case report
Publicado: (2022) -
24. A case of necrotising autoimmune myopathy with recent statin use
por: Charan, Mahima, et al.
Publicado: (2018) -
10. Warning: statin-induced autoimmune necrotising myositis
por: Jasim, Muhamad, et al.
Publicado: (2019) -
Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins
por: Khan, Faris, et al.
Publicado: (2022)